Gujarat

The National Institute of Pharmaceutical Education and Research (NIPER) created as a Centre of Excellence for imparting higher education, research and development in pharmaceutical sciences and management is the first Institute of its kind in the country. The Institute was declared as an Institute of National Importance by Government of India through an Act of Parliament, notified on 26th June 1998. The Institute is a member of the Association of Indian Universities.

SRISTI is a developmental voluntary organization aiming to  strengthen the creativity of/at/for grassroots communities ,including individual innovators. It supports eco-friendly solutions to local problems being scouted, spawned and spread by the Honey Bee Network for over 26 years. It also nurtures ecopreneurs engaged in conserving biodiversity, common property resources, cultural diversity and educational innovators.

SRISTI, an Ahmedabad based developmental voluntary organization in the space of grassroots innovations invites applications from young Copy Editor and Research Fellow committed to work with social purpose.

Shree Dhanvantary Pharmacy College is pioneer educational institute and research centre in south Gujarat region. The institute is located in the sprawling campus of 8.32 acres, in Kim. Shree Dhanvantary Pharmacy College has built its own credentials in a short span of 10 years.

Post: Assistant Professor

Shree Dhanvantary Pharmacy College is pioneer educational institute and research centre in south Gujarat region. The institute is located in the sprawling campus of 8.32 acres, in Kim. Shree Dhanvantary Pharmacy College has built its own credentials in a short span of 10 years.  The institute caters to students opting for B.Pharm, M.Pharm and Ph.D. The institute is offering postgraduate degree in leading branches of pharmacy like Pharmaceutical Chemistry, Pharmacology, Quality Assurance and Pharmaceutics. Shree Dhanvantary Pharmacy College is one among the few institutes having permanent research collaboration with Ribosome Pharma Pvt. Ltd., the FDCA approved Drug Testing Laboratory.

Post : R&D Chemists

CBCC Global Research is an oncology and medical device focused contract research organization serving a wide spectrum of clinical research services including Phase II-IV clinical trials services, medical writing and HEOR related writing, ECG & image core lab services, post marketing registry trials to the Bio-Pharmaceutical, Medical device, and Diagnostics companies. Our close association with our medical advisory board and research communities helps us decode the intricacies of clinical trials targeted at specific therapeutic areas.

National Institute of Pharmaceutical Education and Research (NIPER) is the first national level institute in pharmaceutical sciences with a proclaimed objective of becoming a centre of excellence for advanced studies and research in pharmaceutical sciences. The Government of India has declared NIPER as an 'Institute of National Importance'. It is an autonomous body set up under the aegis of Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India.

Abbott India Limited is a subsidiary of Abbott Laboratories, USA, a global, iversified health care company devoted to the discovery, development, manufacture and marketing of pharmaceutical, diagnostic, nutritional and hospital products. The company now employs approximately 70,000 people and markets its products in 130 countries worldwide.

Piramal Enterprises Limited is the flagship company of the Piramal Group.  Starting from the mid-1980s, PEL has shifted its focus from the textiles industry, and established its entrepreneurial credentials in Pharma, Information Management, and Financial Services. It has grown organically and inorganically and often made contrarian business calls.  When Indian pharmaceutical industry was focused on international generics, we invested in domestic formulation businesses.

Post : Senior Research Associate - AD

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
Jigar Vyas*, Juhi H. Patel, Riya N. Patel, Daxini kapil, Kumar vinodbhai
Sigma Institute of Pharmacy,
Ajwa-Nimeta road, Bakrol, Vadodara, Gujarat

ABSTRACT
Recently, incidences of breast cancer are increasing and it has become a leading cause of cancer related deaths of women globally. Though pharmaceutical and biotechnology industries are developing, and researchers are working to find a better treatment of breast cancer patients to improve the effectiveness of current therapy, the survival rate is very low. A lot of research is going on based on lipid particulate systems which has versatile applications for the treatment of life-threatening diseases such as breast cancer. Out of various lipid particulate systems, liposomes have been studied and explored widely as they have many applications such as improving solubility of antitumor drugs, reduces the side effects, long circulation in blood, possibility of passive and active targeting to tumor cells. Liposomal system is most popular because of its biocompatibility, capability to encapsulate hydrophilic as well as hydrophobic drugs, ease of surface modification and wide range of applications.   Thus, a thorough research is ongoing for upgradation of liposomes as multipotential carriers and its effective therapeutic. Therefore, this review article includes the recent development and techniques of liposomal nano formulations drug delivery system. This review majorly focuses on the breast cancer and its therapy, current challenges in experimental and clinical studies in liposomal formulations.